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Objective: The use of mesenchymal stem cells (MSCs) for cartilage regeneration is hampered by lack of
knowledge about the underlying molecular differences between chondrogenically stimulated chon-
drocytes and MSCs. The aim of this study was to evaluate differences in phenotype and gene expression
between primary human chondrocytes and MSCs during chondrogenic differentiation in three-dimen-
sional (3D) pellet culture (PC).
Materials and methods: Chondrocytes isolated from cartilage samples obtained during total knee
alloarthroplastic procedure (N¼ 8) and MSCs, puriﬁed from bone marrow aspirates of healthy donors
(N¼ 8), were cultivated in PC under chondrogenic conditions. Immunohistology and quantitative reverse
transcribing PCR (RT-PCR) were performed for chondrogenic-speciﬁc markers (i.e., Sox9, Collagen II).
Global gene expression of the so-cultivated chondrocytes and MSCs was assessed by a novel approach of
microarray-based pathway analysis. Reﬁnement of data was done by hypothesis-driven gene expression
omnibus (GEO) dataset comparison. Validation was performed with separate samples in transforming
growth factor (TGF)bþ or TGFb conditions by use of quantitative real-time RT-PCR.
Results/conclusions: Chondrogenic commitment of both cell types was observed. Interestingly, chon-
drocytes demonstrated an upregulated fatty acid/cholesterol metabolismwhich may give hints for future
optimization of culture conditions. The novel microarray-based pathway analysis applied in this study
seems suitable for the evaluation of whole-genome based array datasets in case when hypotheses can be
backed with already existing GEO datasets. Future experiments should further explore the different
metabolic behaviour of chondrocytes and MSC.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) constitutes a major health problem and
biological, non-endoprosthetical osteochondral joint reconstruc-
tion remains a yet unsolved task in the interdisciplinary ﬁeld of
cartilage and bone tissue engineering research. Regenerative
therapy of OA joints has to focus on several features of the
disease1,2, e.g., mechanical imbalance and biological alterations
(chondrocyte senescence or apoptosis, decreased synthesis of
cartilage matrix proteins, inﬂammation).
While some of those issues can be addressed surgically and
pharmacologically, a major challenge remains the regeneration ofPeter Bernstein, Department
s, Fetscherstraße 74, Building
4; Fax: 49-351-449-210413.
den.de (P. Bernstein).
s Research Society International. Pdamaged cartilage by tissue engineering strategies. Although
chondrocytes derived from osteoarthritic donors can be used for
cartilage tissue engineering, their limited availability, quantity, and
viability depict major drawbacks2. The use of alternative cell types
with chondrogenic differentiation potential may offer a solution.
Mesenchymal stem cells (MSCs) have shown to be able to differ-
entiate into cartilage3,4. However, recent data gives conﬂicting
results concerning mechanical quality of MSC-derived cartilage
constructs, suggesting inferior properties of chondrogenic differ-
entiated MSCs5e7. Interestingly, MSCs only exhibit inferior
compressive properties, while tensile properties do not seem to
differ from chondrocytes6,8. The amount of produced extracellular
matrix varies interindividually and depends on the scaffold matrix
used for tissue engineering7. Beside the evaluation of these
mechanical facts, a detailed subcellular and phenotypic comparison
of MSCs with chondrocytes is missing.
Apart from the cellular source, a key factor for successful carti-
lage tissue engineering is three-dimensional (3D) cultivation.ublished by Elsevier Ltd. All rights reserved.
Fig. 1. Data analysis pathway, depicting the three major steps of the analysis process.
(1): microarray-screening and ﬁltering through paths A and B by comparing gene
expression trends, resulting in gene list 1; (2): hypothesis-driven selection of biological
relevant genes, resulting in gene list 2; (3): validation by quantitative RT-PCR.
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a two-dimensional (2D) environment. Sustained chondrogenic
differentiation can only be achieved by the embedding of cells into
biomaterials or by material-free pellet culture (PC)9,10.
PC is a matrix-free 3D cultivation method which has shown to
elicit a considerable chondrogenic effect on chondrocytes and
MSCs9,11,12.
The aim of the study was to compare temporal global gene
expression patterns of PC-conditioned human primary chondrocytes
vshumanbonemarrow-derivedMSCsusingmicroarray-basedglobal
gene expression analysis. As major drawbacks of microarray experi-
ments are the questionable biological relevance of their results at
considerable high costs we ﬁgured out a new approach to cope with
those issues13. To pave theway for further experimentswewanted to
exemplify the validation of our data in transforming growth factor
(TGF)bþ or TGFb conditions. TGFb is a potent stimulator of collagen
biosynthesis, extracellular matrix (ECM) accumulation as well as
mesenchymal cell proliferation and activation14. It therefore can
possibly pronounce pro-chondrogenic effects. In accordance to our
previous work we chose TGF-b3 for our experiments9,15.
Materials and methods
All experiments using OA cartilage tissue were approved by the
local institutional review board (IRB) (protocol number:
EK264122004). MSCs were obtained from the Medical clinic of the
university hospital for which a separate IRB vote exists. All patients’
material was obtained after informed consent.
Isolation and culture of cells
Primary chondrocytes were obtained from osteoarthritic knee
joints during alloarthroplastic procedures from ﬁve female patients
(mean age 74 years, range 61e85 years) for microarray experiments
and from one male and two female patients (mean age 55, range
48e60 years) for polymerase chain reaction (PCR) validation
experiments. MSCs were isolated from iliac crest bone marrow
from ﬁve healthy female donors (mean age 45 years, range 42e48
years) for the microarray experiments and from one male and two
female healthy donors (mean age 54 years, range 42e71 years) for
PCR-validation experiments.
Chondrogenic commitment of the cells used was proofed by
quantitative RT-PCR analysis (Suppl. Table I).
Chondrocytes were isolated by collagenase (Collagenase Type I,
Worthington; Cat.No: CLS1) digestion overnight and expanded in
Dulbecco’s modiﬁed eagle medium (DMEM, Low Glucose, 1x,
Invitrogen, Germany) supplemented with 10% fetal calf serum
(FCS); 1% Penicillin/Streptomycin. Ficoll-gradient separated MSCs
obtained from iliac crest-harvested bone marrow aspirates were
kindly provided by Prof. Martin Bornhäuser. FACS analysis revealed
positivity for CD166, CD105, CD73, CDw90 (all 99%) and CD146
(30e60%) and negativity for CD45, CD34 and CD14 (data not
shown). Passage 0 primary chondrocytes and MSCs, respectively,
were used for the experiments.
Pellet culture (PC)
P0-cells were cultured in high-density PCs, as described previ-
ously9. Brieﬂy, 1.5106 cells were placed into a conical poly-
propylene tube in chondrogenic medium (see below). The cells
were centrifuged at 400 g for 10 min. Cell pellets were cultured in
DMEM with 1% ITS (Insulin-Transferrin-Selenium 100x, Invitrogen,
Germany), 100 U/ml penicillin, 100 mg/ml streptomycin, 210 mmol
ascorbic acid, 10 nmol dexamethasone (SigmaeAldrich, Germany)
and 10 ng/ml TGF-ß3 (Strathmann Biotec, Germany) at 37C, 5%CO2 with medium changes performed every third day. For PCR-
validation experiments, cells were cultivated in the presence or
absence of TGF-ß3 (TGF-bþ/TGF-b).
Histology
For histological analysis, pellets cultured for 2 weeks were ﬁxed
with paraformaldehyde (1%), dehydrated, parafﬁn-embedded and
cut into slices of 1 mm thickness. Immunohistology was performed
using the following antibodies: Collagen I (Clone: COL-1, #C2456,
Sigma, Germany), 1:200; Collagen II (Clone: 2B1.5, #MS-235-P,
ThermoScientiﬁc, Germany), 1:200; Collagen X (Clone: COL-10,
#C7974, Sigma, Germany), 1:500; Sox9 (polyclonal, #AB5535,
Chemicon, Germany), 1:100.
After detection with the appropriate biotinylated secondary
antibody and AB-complex (ABC Standard Kit, Linaris, Germany),
Romulin AEC Chromogen kit (Zytomed, Germany) was used for
staining. All antibodies were test-run with positive controls, every
section was accompanied by a negative control (without primary
antibody) to rule out unspeciﬁc effects.
Histology results were backed by quantitative reverse tran-
scribing PCR (RT-PCR) data (Suppl. Table I).
Isolation of RNA
Total RNA was extracted after 0, 3, 7 and 14 days using a two-
step extraction protocol as described by Hoemann et al.16. Brieﬂy,
one pellet sample was mixed with 350 ml of RLT-b-mercapto-
ethanol solution (RNeasy kit, Qiagen, Germany) and incubated for
30 min at 4C in a thermomixer shaking vigorously. After centri-
fugation at 15,000 g for 10 min at 4C the procedurewas repeated
adding 250 ml of RLT-b-mercapto-ethanol solution followed by
Table I
Gene list 1 after trend-analysis: Analysis path A: initial change from day 0 to day 3 of at least 20,5 and continuous up- or downregulation, differing from the other cell type.
Analysis path B: threshold was set to zero; only those genes showing permanent departure in one distinct direction (up or down) contrasting to the curve of the other cell
Group Path A Path B Group Path A Path B
TGF-b related ID3 Vesicle transport M6PR
FST STXBP5
ID4 SCRN1
Wnt-pathway TBL1XR1 TRAM1
Glycans ADAMTS5 SLC39A10
ACAN1 SH3RF1
MGAT4B CTSB
PLOD1 UBE2A
HS3ST3A1 DDEF2
Actin metabolism LIMA1 SSR4
CNN3 A2M
ACTN1 RNF144A
WDR1 Cellular energy NNT
ACTR2 ABCB10
MYH9 FOXO1
DIAPH3 GYG1
CAPG Mitosis PRC1
Integrins/motility ACTR1A SPINT2 TPX2
ADAM10 GBL Apoptosis BAG2
ITGA8 BOK
GPR124 Stress reaction EPAS1
TUBA1C EIF2AK4
FLNB PENK
RHOB Channel/GTPases KCTD20
LPXN SLC38A6
Bone development TNFRSF11B CLIC4
Muscle development HEG1 PTPLAD1
CFL2 Unclassiﬁed FOSB MTUS1
POPDC3 FRMD6 XIST
Neuronal development BEX1 BEX1 LMCD1 SATB2
PAFAH1B1 LEPROT TDRD1
MAP1B APOBEC3B SYNE2
NTRK2 GRAMD3 FTL
BDNF RCAN2 PTGER2
SEMA3A FAM62A
NR4A2 CCND1
Sperm development RNF141 FAM12A RAB7L1
Lipid metabolism LDLR ATP8A2 FAM83D
SQLE MRGPRF
FADS3 CXorf6
SMPDL3A GCLC
FDFT1 SNX25
ANXA6 FAM46A
SC5DL DUSP23
CYP51A1 RPS20
SGMS1
ACAT1
FDPS
HMGCS1
SC4MOL
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weremixed and the RNeasy procedurewas carried out as described
by the manufacturer.
Microarray analysis
RNA samples from all ﬁve patients of each group were pooled to
obtain sufﬁcient material for further analysis and to mitigate for
interindividual variations. Gene expression proﬁling was per-
formed using N¼ 8 HG-U133 Plus 2.0 arrays (Affymetrix, Santa
Clara, CA, USA). Furthermore biotinylated antisense cRNA was
prepared according to the Affymetrix standard labelling protocol.
Afterwards, the hybridization was performed using a GeneChip
Hybridization oven 640, subsequently dyed in a GeneChip Fluidics
Station 450 and thereafter scanned with a GeneChip Scanner 3000
(all hardware from Affymetrix, High Wycombe, UK).
A Custom CDF (Chip Deﬁnition File) Version 10 with Entrez-
based gene deﬁnitions was used to annotate the arrays. The Rawﬂuorescence intensity values were normalized applying quantile
normalization method, using a commercial software package SAS
JMP7 Genomics, version 3.1, from SAS (SAS Institute, Cary, NC, USA).
All gene expression values were calculated as ratios of the same
cell type relatively to day 0. The raw and normalized data is
deposited in the Gene Expression Omnibus (GEO) database (http://
www.ncbi.nlm.nih.gov/geo/; accession No. GSE19664).
PCR experiments
RNA was reverse transcribed into cDNA using the Omniscript
RT-Kit (Qiagen, Germany) and dT18-oligonucleotides.
Quantitative PCR experiments were performed on days 7 and 14
on a MX4000 Multiplex Quantitative PCR machine (Stratagene, The
Netherlands) using the appropriate PCR kits (Brilliant Multiplex
and SYBR green Master Mix) and selected oligonucleotides
(sequences can be obtained from the author). The reaction protocol
included an initial denaturation step for 10 min at 95C which was
P. Bernstein et al. / Osteoarthritis and Cartilage 18 (2010) 1596e1607 1599followed by 40 cycles (30 s 95Ce1 min 60Ce30 s 72C). Quanti-
ﬁcation was carried out in duplicates, gene transcription was
normalized to the GAPDH-value of the same experiment and time
point. PCR reactions were carried out in a Stratagene Real-Time PCR
System.
Data analysis
Data analysis was splitted in a screening process (Microarray
step¼ gene list 1), interpretative analysis against GEO datasets
(gene list 2) and a quantitative validation step via quantitative
RT-PCR. The whole analysis process is outlined in Fig. 1.
Gene list 1: microarray data trend-analysis
Gene expression dynamics were analyzed from day 3 to day 14
as follows. All genes with an initial fold-change in expression from
day 0 to day 3 of at least >20,5 were included for further analysis.
Curves were classiﬁed as either constantly upregulated, constantly
downregulated, or not constantly (¼unsteady) regulated. If curve
classiﬁcation revealed inequality between MSCs and chondrocytes
(e.g., MSC¼ up, chondrocytes¼ unsteady) the respective gene was
added to gene list 1 (Fig. 1, path A). Curves of the genes not fulﬁlling
the initial threshold of 20,5 but showing constant dissimilarity of
both curves (e.g., MSC¼ up, chondrocytes¼ down)were also added
to gene list 1 (Fig. 1, path B). Genes were annotated to functionally
distinct groups by use of gene ontology (GO) terminology.
Gene list 2: trend comparison
Biologically relevant background data was retrieved by a GEO
search that included keywords such as “chondrocyte” or “MSC”.
GEO proﬁle datasets were required to represent a time-based
observation under standardized culture conditions. It therefore
resulted in a panel of GEO datasets covering processes of mesen-
chymal limb bud development, tissue engineering, and regenera-
tion after injury (see Table II).
Regulation curves of the genes in gene list 1 (Table I) were
manually compared with the respective gene regulation of the
selected GEO dataset from Table II. It was decided, if the curve trend
ﬁtted to the MSC or the chondrocyte behaviour. In cases with
multiple differently regulated samples, even a both-like (MSC andTable II
Panel of GEO datasets used for comparison and selection of genes backed by the justifyi
GEO dataset and
reference
Biological process Tissue culture system Cultivation
GDS1865 James
et al.23
Endochondral
differenttiation
pathway
Murine micromass culture
of E11.5 mouse embryo
limb buds
2:3 DMEM/F12, 1
0.5 mM glutamin
25 U/ml penicillin
25 mg/ml streptom
0.25 mM ascorbic
1 mM b-glycerop
GDS3062 Larson
et al.24
Transition from
proliferation to
differenttiation
P2-Human MSC 2D culture;
5% conﬂuence until
70% conﬂuence
a-minimal essent
17% FBS, 2 mM gl
100 U/ml penicill
100 mg/ml strepto
GDS1404 Cameron
et al.46
Retina
regeneration
Zebraﬁsh retina injury Fresh tissue
GDS234 Zhao
et al.47
Muscle
regeneration
Cardiotoxin e mediated
muscle injury
(mouse model)
Fresh tissue
GDS63 Di Giovanni
et al.48
Neuronal
regeneration
Spinal cord injury
(rat model)
Fresh tissuechondrocyte) behaviour could be attested. Qualifying genes were
added to gene list 2 (Table III). Otherwise genes were given the
status “no similarity”. If the speciﬁc gene was not present in the
GEO dataset, the status “not available (NA)” was given.
Validation step: PCR quantiﬁcation and statistics
Functionally distinct genes from gene list 2 (Fig. 1) were further
analyzed via quantitative RT-PCR method. All primers used were
validated for speciﬁcity by gel electrophoresis of their respective
products (data not shown). Data is presented as means. Statistical
signiﬁcance was calculated with ANOVA, using SPSS 17 (SPSS Inc.,
Chicago, US). P-values< 0.05 were considered signiﬁcant.
Results
Immunohistology
PC-conditioned chondrocytes showed Sox9-expression compa-
rable to MSCs with a trend towards more intranuclear retention
[Fig. 2 (A) and (B)]. Collagen staining demonstrated a clear supe-
riority of collagen type II over type I. This effect was pronounced in
chondrocytes, whereas staining in MSCs appeared to be weak
[Fig. 2 (C)e(F)]. Both cell types stained highly positive for collagen X
[Fig. 2 (G) and (H)].
Validation was carried out by quantitative RT-PCR of the
respective genes and showed a signiﬁcant higher Sox9-expression
in chondrocytes, whereas collagen type I, II and X did not differ
signiﬁcantly (Suppl. Table I).
Microarray analysis
Whole-genome expression data were compared between
chondrocytes and MSCs at various time points (days 0, 3, 7, 14,
Fig. 3, line A). Most similarity, i.e., 95%, of genetic expression
between MSCs and chondrocytes existed at time point zero (start).
During cultivation cell type-speciﬁc differences were observed,
reducing similarity to 92% at day 14.
When comparing monolayer-cultivated P0-MSCs (MSC, day 0)
with different stages of chondrocyte pellet redifferentiation (days 3,
7, 14, Fig. 3, line C), decreasing similarity from 95% down to 83%ng hypotheses
Analysis Justifying hypothesis for
selection as a comparison tool
0% FBS,
e,
,
ycin,
acid,
hosphat
 Affymetrix MOE430A
(w14,000 probe sets)
 Three replicates, aiming
at the difference between
d15 and d3
 d0, d3, d6, d9, d12, d15
MSC differentiation in limb
buds will resemble most
parts of MSC differentiation
towards the chondrogenic
lineage.
ial medium,
utamine,
in,
mycin
 Affymetrix HG-U133 Plus
2.0 (w31,000 probe sets)
 Three replicates aiming
at the difference between
d2 and d7
 d2, d7
An increasing conﬂuence of
proliferating MSCs will
resemble the pellet situation
in a timely delayed manner.
 Affymetrix Zebraﬁsh
Genome Array
 d2, d3, d5, d14
In vivo regenerative processes
will resemble MSC differentiation
in PC, depending on the
similarity of tissues.
 Affymetrix Murine Genome
U74A version 1
 Two replicates
 d0, 12 h, d1, d2, d4, d10
Pellet MSC would behave
more similar to muscle
regeneration than retina or
neuronal regeneration.
 Affymetrix rat U34A array
 Two replicates
 30 min, 4 h, 24 h, 7d
Table III
Gene list 2: results of the trend comparison of GEO datasets with chondrocyte or MSC PC. C¼GEO gene behaves like chondrocytic PC, M¼GEO gene behaves like MSC PC,
CþM¼GEO gene is similar to chondrocytes and MSC
GEO-comparison with chondrocyte PC (C) and MSC-pellet culture (M)
Functional group/gene GDS1865
“limb bud”
GDS3062
“MSC
conﬂuence”
GDS1404
“retina”
GDS234
“muscle”
Actin-metabolism ARP2 actin-related protein 2 homolog (ACTR2) C CþM e e
Capping protein (actin ﬁlament, CAPG) C e e e
Myosin, heavy chain 9, non-muscle (MYH9) C CþM e e
LIM domain and actin binding 1 (LIMA1) e CþM C M
Actinin, alpha 1 (ACTN1) e e e M
Calponin 3, acidic (CNN3) e e e M
Glycan-metabolism Aggrecan (ACAN) C C e C
ADAM metallopeptidase with thrombospondin motif (ADAMTS5) C C e e
Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase,
isozyme B (MGAT4B)
C M e e
Integrins ADAM metallopeptidase domain 10 (ADAM10) e C e M
TGFb related Inhibitor of DNA binding 3, dominant negative (ID3) C M e M
Inhibitor of DNA binding 4, dominant negative (ID4) C M e e
Follistatin (FST) C e e M
Muscle development HEG homolog 1 (zebraﬁsh, HEG1) e C e e
POPDC3 e C e e
Coﬁlin 2 (muscle, CFL2) e CþM e e
Neuronal development Brain-derived neurotrophic factor (BDNF) e M e M
Brain expressed, X-linked 1 (BEX1) e M e C
Platelet-activating factor acetylhydrolase, isoform Ib, alpha subunit 45 kDa
(PAFAH1B1)
e C e C
Nuclear receptor sub-family 4, group A, member 2 (NR4A2) e M C e
Lipids/steroids/
cholesterol
Acetyl-Coenzyme A acetyltransferase 1 (ACAT1) M e e e
Cytochrome P450 oxidase, family 51, sub-family A , polypeptide 1 (CYP51A1) M C e e
Farnesyl-diphosphate farnesyltransferase (FDFT1) M M e e
Farnesyl-diphosphate synthase (FDPS) M M e M
Low density lipoprotein receptor (LDLR) M e e M
Squalene epoxidase (SQLE) M M e M
Sterol-C4-methyl oxidase-like (SC4MOL) e M e e
Fatty acid desaturase 3 (FADS3) C C e e
HMGCS1 e C e e
Vesicle transport Cathepsin B (CTSB) C C e e
Solute carrier family 39, type 10 (SLC39A10) e CþM e e
Syntaxin binding protein 5 (tomosyn, STXBP5) e CþM e e
Translocation associated membrane protein 1 (TRAM1) e CþM e e
Channels CLIC4 C C C e
Cellular energy NNT M C e C
ATP-binding cassette, sub-family B (ABCB10) e e e C
Glycogenin 1 (GYG1) e e e C
Ferritin, light polypeptide (FTL) C C e M
Not further classiﬁed Cyclin D1 (CCND1) C M e e
FBJ murine osteosarcoma viral oncogene homolog B (FOSB) C M e M
Leptin receptor overlapping transcript (LEPROT) C C e e
FERM domain containing 6 (FRMD6) C e e e
MAS-related GPR, member F (MRGPRF) C e e e
RAB7, member RAS oncogene family-like 1 (RAB7L1) C C e e
Spectrin repeat containing, nuclear envelope 2 (SYNE2) C e e e
Tudor domain containing 1 (TDRD1) C e e e
Family with sequence similarity 83, member D (FAM83D) e C e e
Regulator of calcineurin 2 (RCAN2) e M e e
Dual speciﬁcity phosphatase 23 (DUSP23) e CþM e e
Family with sequence similarity 62 (FAM62A) e CþM e e
GRAM domain containing 3 (GRAMD3) e CþM e e
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P0-chondrocytes (chondrocytes, day 0) with different stages of
chondrogenicMSC-pellet cultivation (days 3, 7,14, Fig. 3, line B), the
gain of difference between both cell types was smaller (compare
lines C vs B), ranging from 95% down to 90% similarity.
Microarray data trend-analysis was done as shown in Fig. 1. Data
reduction using path A resulted in 95 genes (gene list 1, see Table I),
of which most belonged to lipid/cholesterol pathway, actin and
integrin pathway as well as to vesicle transport systems.
Applying path B resulted in 12 genes, belonging to integrins,
sperm and lipid metabolism. The gene brain expressed, X-linked 1
(BEX1) is represented in both analysis pathways as it shows char-
acteristics of path A and B.Most genes of gene list 1 demonstrate a ﬁnal gene expression
increase in chondrocytes during pellet cultivation (Fig. 4).
GEO trend comparison
GEO database search resulted in ﬁve datasets which are
described more precisely in Table II. One hundred and seven genes
from gene list 1 were manually compared with the trends of the
genes or their homologues in the mentioned datasets. It could be
demonstrated that in the group “differentiating limb buds”
(GDS1865) 45 genes showed similar regulation to either MSCs or
chondrocytes or both; in the group “conﬂuently growing MSCs”
(GDS3062) there were 62 genes showing similar patterns. In the
Fig. 2. Immunohistological staining of chondrocyte (A, C, E, G) and MSC pellets (B, D, F, H) reveals sufﬁcient Sox9-expression (A, B) and only limited intranuclear retention in MSC
(B). Collagen I is produced on a low level in both cell types (C, D). Collagen II is highly upregulated in chondrocytes (E) as opposed to MSCs (F). Both cell types show an upregulated
expression of collagen X (G, H). Sections are representative for larger areas of the specimen. Scale bars¼ 20 mm.
P. Bernstein et al. / Osteoarthritis and Cartilage 18 (2010) 1596e1607 1601groups “retina regeneration” (GDS1404) and “muscle regeneration”
(GDS234) only nine and 30 genes, respectively, showed a similar
regulation. The group “neuronal regeneration” (GDS63) resulted in
15 comparable genes. Due to this low sample size, further analysis
within this group was not carried out.The result of the similarity of chondrocytes and MSCs with GEO
datasets in temporal gene expression levels is summarized in gene
list 2 (Table III).
A minimum of one gene out of each functional group, occurring
in more than one GEO datasets and matching to chondrocyte or
Fig. 3. Multivariate correlation matrix of genetic expression similarity between chondrocytes and MSCs compared with the monolayer startpoint (day 0) during pellet cultivation
until day 14. Line A: Similarity between chondrocytes and MSCs; line B: similarity between dedifferentiated day-0 chondrocytes and pellet-cultured MSCs; line C: similarity
between day-0 MSCs and pellet-cultured chondrocytes.
P. Bernstein et al. / Osteoarthritis and Cartilage 18 (2010) 1596e16071602MSC behaviour in PC, was arbitrarily selected for further PCR
experiments (if possible, at least one gene out of each GO-group
with key relevance to the respective pathways).
PCR quantitative analysis
Regardless of TGFb supplementation, aggrecan (ACAN1)
expression levels were approximately 20e30-fold increased in
chondrocytes compared to MSCs in the ﬁrst and second weeks of
cultivation (Fig. 5). Of all the other genes, only inhibitor of DNA
binding (ID4) was expressed signiﬁcantly (30-fold) by chondrocytes
and MSCs after 2 weeks of cultivation with TGFb.
Low-value-difference patterns were visible for chloride intracel-
lular channel 4 (CLIC4), being expressed 1,1e1,5-fold (week 1eweek
2, TGFbþ) or 2,1e2,6-fold (TGFb) higher in chondrocytes, reaching
signiﬁcance only in the TGFb group. A similar trend could be
observed for the 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1
(HMGCS1),whichwas 1,1e1,6-fold (TGFbþ) or 2,1e2,8-fold (TGFb)
higher in chondrocytes, although only close to signiﬁcance.
Signiﬁcant upregulation could be seen in the chondrocytic
ADAM metallopeptidase (ADAMTS5) only under TGFb conditions
(2,3e2,8-fold), in the ﬁrst-week chondrocytic nicotinamide nucle-
otide transhydrogenase (NNT, 2,1-fold) and in the second-week
chondrocytic cytochrome P450 oxidase (CYP51A1, 3,7-fold).
The chondrocytic gene popeye domain containing 3 (POPDC3)
showed a signiﬁcant reduction of expression in the second week
under TGFb-stimulation to 30% of the MSC-value.
The other geneswere lowand not signiﬁcantly regulated (Fig. 5).
Of the signiﬁcantly regulated genes, chondrocytic aggrecan
(ACAN1) and POPDC3 showed the least sensitivity to TGFb-regu-
lation, whereas a reduction of chondrocytic CYP51A1 (0,77-fold),
CLIC4 (0,56-fold), NNT (0,54-fold), ADAMTS5 (0,4-fold) and ID4
(0,09-fold) could be observed (Fig. 5).
Discussion
In the ﬁeld of cartilage tissue engineering there is a major need
for a sufﬁcient yield of cells. Since healthy cartilage offers only 5%cells/volume, an even lower amount of chondrocytes is usually
harvested from diseased joints17. MSC has shown to possess
suitable chondrogenic potency18. However, MSC-derived chon-
drocytes show inferior mechanical properties and produce less
extracellular matrix proteins compared with primary
chondrocytes19.
We therefore investigated whether we could depict gene
expression differences between chondrocytes and MSCs during
chondrogenic redifferentiation by PC.
Commitment to chondrogenic differentiation
We have started our experiments by conﬁrming chondrogenic
commitment of PC-conditioned chondrocytes and PC-conditioned
MSC immunohistologically and by quantitative RT-PCR analysis of
Sox9, collagen type I, II and X.
Chondrocytes and MSC, showed a ready progression
towards the chondrogenic lineage. Sox9-expression was higher
in chondrocytes accompanied by an immunohistological notion
of more intranuclear retention. Although there were no
signiﬁcant differences in collagen I and II mRNA expression,
our data suggests that MSC’s may be less efﬁcient at trans-
lating, processing or incorporating collagen into the extracel-
lular matrix.
Chondrogenic arrest is missed and both cell types proceed
towards hypertrophy. This, being a still unsolvedmajor drawback of
in vitro culture systems, has been described before in more
detail19,20.
Analysis strategy
Classical ways of microarray analysis use a number of replicates
for each study point and try to ﬁlter biological information in
a more or less computed fashion21. The involved procedures rely on
statistical methods that are still ﬂawed by difﬁculties (e.g., multiple
testing) and uncertainties about the biological relevance of the
results13,22. Alternatively, we used a serial approach, including
microarray-screening, GEO-comparison and PCR validation of
Fig. 4. Trend-distribution matrix showing the ﬁnal difference in gene expression between day 14 and day 3 (dynamics) of selected genes from gene list 1 from chondrocytes and
MSCs, cultivated as pellets. A dynamic value> 0 represents an increasing expression.
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pooling of samples, statistical relevance cannot be calculated.
Hence, this denotes a potential limitation of the study that was
dealt within the further experimental design. First, biological
variationwas already incorporated through the pooling of samples.
Second, we underweighted microarray data and did not attempt to
implement statistical safety in the beginning. We used the two
microarray “clouds” of chondrocyte and MSC behaviour to ﬁlter out
the differences. Omitting doubtful statistical procedures had the
advantage of gaining a high sensitivity in the screening process.
Low speciﬁcity is raised in a step-wise manner as described in the
methods section. We analyzed the microarray data against an
arbitrarily selected, biologically relevant background of regenera-
tive processes, assessed through carefully conducted microarray
experiments. In contrast to a non-hypothesis-driven analysis, often
performed in whole-genome expression analysis experiments, we
generated hypotheses for every GEO dataset (Table. II). Notably, this
approach facilitated to narrow the scope of candidate genes and
allowed for the interpretation from a system-biological point of
view. However, there are clear limitations: hypothesis-driven
microarray analysis only works when statistically safe background
data is available.Result of hypothesis testing
For example, in contrast to the initial hypothesis, chondrocyte PC
resembled limb bud outgrowth23 more likely than MSC did. Regu-
latory similaritiesweremore likely tobe seen in chondrocytic PCand
were more closely related to the chondrogenic pathway. Another
hypothesiseMSC PCs would be closer related to 2D-MSCs reaching
conﬂuence e was also falsiﬁed: 2D-expansion of MSCs resembled
changes occurring in chondrocytic PCs more likely than inMSC PCs.
This accounts especially for differences that were validated for
the cholesterol pathway and for chondrogenic marker genes. One
might be tempted to accuse the high-serum conditions used in the
reference experiment “conﬂuently growing MSCs”24 to explain the
unexpected similarity between cell layer-cultivated MSC and
chondrocytes cultured in 3D PC.
To gain more insight into the validity of the observed trends,
validation experiments were performed using quantitative RT-PCR.
Triggers of chondrogenic effects
In contrast to the observed phenotypic and functional differ-
ences, chondrocytes expressed signiﬁcantly more aggrecan
Fig. 5. Results of quantitative RT-PCR validation of gene expression differences between chondrocytes and MSC in the ﬁrst and second week of PC in TGFb and TGFbþ culture
conditions (n¼ 6 patients, see material part). P-values of signiﬁcant differences are indicated above the bars. Error bars show 95% conﬁdence interval.
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tively. Supposedly to support aggrecan production, the aggrecanase
ADAMTS5 was downregulated in chondrocytes. This occurred only
under the inﬂuence of TGF-b as has been shown before25e27 and
correlates well with other already described pro-chondrogenic
effects of TGF-b, e.g., its chondro-protective effect in osteoarthritic
joints28, its role in preventing terminal endochondral differentia-
tion29, and its beneﬁcial use in cartilage tissue engineering30.
TGF-b-driven effects denote an example of the sensitivity of cell-
based constructs towards culture conditions.Although not included in RT-PCR-validation, chondrocytic
upregulation of the glucosaminyltrans-ferase MGAT4B demon-
strated the increased glycano-anabolic activity in chondrocytes
when compared with MSCs.
Fatty acid metabolism and cholesterol biosynthesis
Most strikingly, chondrocytes showed an upregulated fatty acid
metabolism (CYP51A1, FADS3, SMPDL3A) and cholesterol-/sterol
biosynthesis-pathway (FDFT1, FDPS, HMGCS1, LDLR, SC4MOL,
P. Bernstein et al. / Osteoarthritis and Cartilage 18 (2010) 1596e1607 1605SC5DL, SQLE) in the microarray-screening. Chondrocytic upregu-
lationwas validated for HMGCS1 and the cytochrome P450 oxidase
CYP51A1, thus verifying an increased cholesterol-biosynthetic
activity in chondrocytes.
This phenomenon was discovered earlier as a speciﬁc feature of
growth plate chondrocytes31. The importance of the cholesterol-
biosynthetic pathway for chondrocyte and limb bud development
has been demonstrated by linking it to hedgehog signalling32e34,
nuclear receptor roralpha35 and to liver X and retinoid receptors36.
MSCs, however, do not upregulate their cholesterol biosynthesis,
which could be interpreted as a hint that their original cellular
signalling context is located farther away from the joint lineemore
towards bone37.
MSC in their relation to bone
Osteoprotegerin (TNFRSF11B) upregulation underlines the
speciﬁc feature of MSCs to readily undergo osseous differentia-
tion38,39. Compared to chondrocytes, their suitability for a regen-
erative cartilage therapy seems therefore to be limited e at least
under the conditions used in our experimental setting.
Other differences between chondrocytes and MSC
ID-Proteins function as Corepressors by binding of Helix-Loop-
Helix motifs of tissue-speciﬁc transcription factors. Higher
expression of the inhibitors of DNA binding ID3 and ID4 inMSCse as
was detected in our experimentse can be indicative for a sustained
undifferentiated state40.
Downregulation of the eukaryotic translation initiation factor
EIF2AK4 marks an increase of protein biosynthesis in MSCs41. Pro-
enkephalin (PENK) and endothelial PAS domain protein 1 (EPAS1) are
hypoxia-responsive genes that support angiogenesis42. This seems
to be an answer of oxygen-deprived MSC (due to PC condition) that
cannot be seen in chondrocytes.
Chondrocytes expressed more of the intracellular chloride
channel CLIC4, a conserved gene among vertebrates. CLIC4 was
shown to be a mediator of TGF-b signalling via its translocation to
the nucleus. Although its function is not yet clear, it seems to have
some relevance in endothelial tubule formation, anti-apoptotic
action and ﬁbroblast-to-myoﬁbroblast-transdifferentiation in
cancer cells43,44. Despite its primary description as an intracellular
channel, involvement in cellular volume regulation could be
a function of the untranslocated protein45.
Conclusion
Phenotype and gene expression of chondrocytes and MSCs
differ during chondrogenic PC. Our data suggests, that MSC in
simple PC do not seem to reach the same stage of chondrogenic
differentiation as chondrocytes do, regardless of TGFb-supple-
mentation and despite harvesting from younger and healthier
donors. Most strikingly, MSCs show a reduced expression of
chondrogenic matrix proteins, e.g., collagen II and aggrecan. On the
other side, MSCs are more rapidly prepared for an osseous trans-
formation. A speciﬁc metabolic aspect of chondrocytes, that has not
been described in comparison with MSCs before, is their upregu-
lated fatty acid/cholesterol biosynthesi-pathway. This pathway
may be a potential target for optimization of chondrogenic MSC
culture conditions.
We interpreted our data in the background of already existing
datasets, thus bringing it closer to biological relevance. This may be
an advantageous choice in cases when hypotheses can be backed by
already existing expression data. However, this might not be thecase for other situations when such data does not exist and
statistical safety is important to the whole-genome dataset.
Future experiments should explore the different metabolic
behaviour of chondrocytes and MSC and their biological relevance.
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